mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.03 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.03 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |